Creative Biolabs-Immuno-oncology

Anti-CD56 (clone N9Q0Z1G) SynExpress T7-BF-β-Sm Modified CD8+ T cells (CAT#: ITS-1224-CR1712)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD56 (clone N9Q0Z1G). We employs the Retrovirus (T7-BFP-β-catenin-SmaI) vector components and the SynExpress system of the Single base pair Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD56
Clone
N9Q0Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
T7
Effector Gene
β-catenin
Insertion Sites
SmaI
Gene Modification
Base Editing
Modification Domain
Single base pair
Carrier Type
Retrovirus
Transformation Accuracy
0.98
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.